首页> 外国专利> Formulation for controlled release in the tympanic chamber of drug comprising N-acylated glycol chitosan

Formulation for controlled release in the tympanic chamber of drug comprising N-acylated glycol chitosan

机译:含有N-酰化乙二醇壳聚糖的药物鼓室中控释的制剂

摘要

N-acylated glycol chitosan has amphiphilic properties, so it can support both hydrophilic and hydrophobic drugs, and a sol-gel phase transition occurs in the tympanic chamber, which can increase the residence time in the tympanic chamber, has no side effects, and can be used as a drug Depending on the type or concentration, the drug can be released in immediate or sustained release, so it can be useful for intratympanic drug delivery and treatment of inner ear diseases.
机译:N-酰化乙二醇壳聚糖具有两亲性,因此可以同时支持亲水性和疏水性药物,并且在鼓室中发生溶胶-凝胶相变,可以增加在鼓室中的停留时间,无副作用,可作为药物使用,根据类型或浓度,药物可以立即或持续释放, 因此,它可用于鼓室内药物递送和内耳疾病的治疗。

著录项

  • 公开/公告号KR1026617660000B1;KR2024102661766B1;KR102661766B1;

    专利类型

  • 公开/公告日2024-04-26

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020210131088;KR202100000131088A;KR20210131088A;

  • 发明设计人

    申请日2021-10-01

  • 分类号A61K9;A61K31/573;A61K47/36;A61K9/16;A61P27/16;

  • 国家

  • 入库时间 2024-06-15 00:13:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号